Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Position Increased by CENTRAL TRUST Co
10:40am, Sunday, 19'th Apr 2020
CENTRAL TRUST Co raised its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 25.2% in the 1st quarter, Holdings Channel reports. The firm owned 13,356 shares of the specialty pharmaceut
Free jazz legend Giuseppi Logan dead of coronavirus at 84
12:17am, Sunday, 19'th Apr 2020
Jazz legend Giuseppi Logan died of the coronavirus at a Far Rockaway nursing home, according to a report. He was 84. Logan, who became an icon in New York’s free jazz movement in the 1960s, died at�
Zacks: Analysts Anticipate Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Will Announce Earnings of $0.62 Per Share
10:32am, Saturday, 18'th Apr 2020
Analysts expect Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) to post $0.62 earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have issued estimates for Jazz Pharmaceuticals’ e
Introducing Jazz Pharmaceuticals (NASDAQ:JAZZ), The Stock That Dropped 43% In The Last Five Years
06:16pm, Friday, 17'th Apr 2020
Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both...
FY2022 EPS Estimates for Jazz Pharmaceuticals PLC Cut by SVB Leerink (NASDAQ:JAZZ)
08:14am, Friday, 17'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Equities researchers at SVB Leerink dropped their FY2022 earnings estimates for shares of Jazz Pharmaceuticals in a note issued to investors on Monday, April
Jazz Pharmaceuticals (JAZZ) Received its Third Buy in a Row
07:01am, Friday, 17'th Apr 2020
After Merrill Lynch and RBC Capital gave Jazz Pharmaceuticals (NASDAQ: JAZZ) a Buy rating last month, the company received another Buy, this time from
Jazz Pharmaceuticals (JAZZ) Received its Third Buy in a Row
07:00am, Friday, 17'th Apr 2020
After Merrill Lynch and RBC Capital gave Jazz Pharmaceuticals (NASDAQ: JAZZ) a Buy rating last month, the company received another
Global Acute Myeloid Leukemia (AML) Therapeutics Industry
05:22am, Friday, 17'th Apr 2020
New York, April 17, 2020 -- Reportlinker.com announces the release of the report "Global Acute Myeloid Leukemia (AML) Therapeutics Industry" -.
Jazz Pharmaceuticals (JAZZ) Receives a Buy from Oppenheimer
07:12pm, Thursday, 16'th Apr 2020
In a report released today, Esther Rajavelu from Oppenheimer maintained a Buy rating on Jazz Pharmaceuticals (JAZZ), with a price target of $154.00. The
Jazz Pharmaceuticals (JAZZ) Receives a Buy from Oppenheimer
07:11pm, Thursday, 16'th Apr 2020
In a report released today, Esther Rajavelu from Oppenheimer maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report),
Utah Jazz Fan Favorites And Glue Guys From The Last Decade
01:18pm, Thursday, 16'th Apr 2020
With Utah Jazz fan favorite Trevor Booker announcing his retirement, who are some other beloved Jazz players from recent seasons?
BRIEF-Jazz Pharma Says Porton Biopharma Entered Into New Agreement With New Partner To Commercialize & Distribute Erwinaze
11:15am, Thursday, 16'th Apr 2020
Jazz Pharmaceuticals PLC:
FY2020 EPS Estimates for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Reduced by SVB Leerink
06:14am, Thursday, 16'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Equities researchers at SVB Leerink reduced their FY2020 EPS estimates for shares of Jazz Pharmaceuticals in a research note issued on Monday, April 13th. SV
Guggenheim Capital LLC Has $12.07 Million Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
10:38am, Wednesday, 15'th Apr 2020
Guggenheim Capital LLC lifted its stake in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 44.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange
